Liquidia to release Q1 2026 financial results on May 11 with live webcast.

Liquidia Corporation announced it will report its first quarter 2026 financial results on May 11, 2026, and host a live webcast at 8:30 a.m. Eastern Time to discuss the results and provide a corporate update. The company specializes in innovative therapies for respiratory and vascular diseases, including its approved drug YUTREPIA® for pulmonary hypertension. Investors and interested parties can access the webcast on Liquidia’s website, with a rebroadcast available for one year. This update will offer insights into the company’s financial performance and ongoing developments in its drug pipeline.